Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Tine Hylle, Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00760695
First received: September 25, 2008
Last updated: May 8, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)